Biktarvy 50 MG / 200 MG / 25 MG Oral Tablet

RxCUI: 1999673
RxNorm name: Biktarvy 50 MG / 200 MG / 25 MG Oral Tablet
Display name: Biktarvy 50 MG / 200 MG / 25 MG Oral Tablet
Full name: Biktarvy 50 MG / 200 MG / 25 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Biktarvy	BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE	Gilead Sciences, Inc.	664cb8f0-1f65-441b-b0d9-ba3d798be309	2026-07-07	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1999673
Biktarvy	BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE	A-S Medication Solutions	0476d7eb-1024-4821-bbe7-abaacfda32a2	2024-04-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1999673

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
664cb8f0-1f65-441b-b0d9-ba3d798be309	Biktarvy 50 MG / 200 MG / 25 MG Oral Tablet [PSN] · bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Biktarvy] [SBD] · Biktarvy 50 MG / 200 MG / 25 MG Oral Tablet [SY]	3	24	These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018	20260330
0476d7eb-1024-4821-bbe7-abaacfda32a2	Biktarvy 50 MG / 200 MG / 25 MG Oral Tablet [PSN] · bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Biktarvy] [SBD] · Biktarvy 50 MG / 200 MG / 25 MG Oral Tablet [SY]	3	5	These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018	20240430